Android app on Google Play

Questcor (QCOR) Under Pressure on Continue Reimbursement Worries

December 27, 2012 11:43 AM EST Send to a Friend
Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) sees pressure as traders pass around a Blue Cross/Blue Sheild of Michigan Drug Review showing the company's Acthar is only covered for infantile spasms.


Shares of QCOR last traded at $27.80, down 7%.

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment